Filing Details
- Accession Number:
- 0001765581-19-000086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-14 17:33:58
- Reporting Period:
- 2019-08-12
- Accepted Time:
- 2019-08-14 17:33:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615763 | Paul Treacy | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Svp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2019-08-12 | 4,371 | $137.40 | 16,418 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 106 | Indirect | by Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.4015 to $137.4322, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Includes 140 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2019.
- Represents ordinary shares purchased by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme on March 15, 2019 in a transaction exempt under Rule 16b-3(c).